日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemoresistance in PDAC

Elesclomol-铜组合协同靶向癌干细胞的线粒体代谢,以克服胰腺导管腺癌的化疗耐药性。

Qian Yu ,Ke Jiang ,Siyu Ma ,Quan Zheng ,Serena Tondi ,Chiara Reina ,Berina Šabanović ,Chenlei Wen ,Baiyong Shen ,Alexandra Aicher ,Haiyun Song ,Yinxing Ma ,Christopher Heeschen

Exchange of subtelomeric regions between chromosomes 4q and 10q reverts the FSHD genotype and phenotype

4q 和 10q 染色体之间的亚端粒区域交换会逆转 FSHD 基因型和表型

Yinxing Ma, Anna Schwager Karpukhina, Carla Dib, Candice Gautier, Olivier Hermine, Eric Allemand, Yegor S Vassetzky

Progress in the clinical application of constraint-induced therapy following stroke since 2014

自2014年以来,约束诱导疗法在中风后临床应用方面取得了进展

Cui, Yinxing; Ma, Ningyi; Liu, Xuncan; Lian, Yawen; Li, Yinghua; Xu, Guoxing; Zhang, Jiaming; Li, Zhenlan

Analysis of genes regulated by DUX4 via oxidative stress reveals potential therapeutic targets for treatment of facioscapulohumeral dystrophy

通过氧化应激对 DUX4 调控的基因进行分析,揭示了治疗面肩肱型营养不良症的潜在治疗靶点

Anna Karpukhina, Ivan Galkin, Yinxing Ma, Carla Dib, Roman Zinovkin, Olga Pletjushkina, Boris Chernyak, Ekaterina Popova, Yegor Vassetzky

The SEACIT complex is involved in the maintenance of vacuole-mitochondria contact sites and controls mitophagy

SEACIT 复合物参与液泡-线粒体接触点的维持并控制线粒体自噬

Yinxing Ma, Alexis Moors, Nadine Camougrand, Svetlana Dokudovskaya

Tumor suppressor NPRL2 induces ROS production and DNA damage response

肿瘤抑制因子 NPRL2 诱导 ROS 产生和 DNA 损伤反应

Yinxing Ma, Licia Silveri, John LaCava, Svetlana Dokudovskaya

PMS1077 sensitizes TNF-α induced apoptosis in human prostate cancer cells by blocking NF-κB signaling pathway

PMS1077 通过阻断 NF-κB 信号通路增强 TNF-α 诱导的人类前列腺癌细胞凋亡

Jie Shi, Jing Chen, Nawal Serradji, Ximing Xu, Heng Zhou, Yinxing Ma, Zhihong Sun, Peng Jiang, Yuping Du, Jinbo Yang, Changzhi Dong, Qin Wang